SCHEMBL3699265

SCHEMBL3699265

Cc1ccc(-c2cc(-c3ccc(-c4ccccc4)cc3)nc3c2ccc2c(-c4ccc(C)cc4)cc(-c4ccc(-c5ccccc5)cc4)nc23)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.56
ALDH1A1 P00352 5/20 0.56
MAPT P10636 5/20 0.56
HPGD P15428 5/20 0.56
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
TDP1 Q9NUW8 2/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
NPSR1 Q6W5P4 3/20 0.54
LMNA P02545 3/20 0.54
RECQL P46063 1/20 0.54
AGTR1 P30556 1/20 0.51
PPARG P37231 2/20 0.51
NCOA2 Q15596 1/20 0.51
NCOA1 Q15788 1/20 0.51
NCOA3 Q9Y6Q9 1/20 0.51
ADORA2A P29274 1/20 0.51
ADORA1 P30542 1/20 0.51
SLC2A1 P11166 1/20 0.50
ALDH1A3 P47895 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3697872 1.00 KDM4E (0.56) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL13458698 1.00 KDM4E (0.56) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL13458834 1.00 KDM4E (0.56) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL13458726 0.98 KDM4E (0.57) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL14560694 0.98 KDM4E (0.57) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL29455177 0.98 KDM4E (0.57) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL3358750 0.91 ACACA (0.50) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL3358457 0.91 ACACA (0.50) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL17899330 0.91 ACACA (0.50) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL3698074 0.91 ACACA (0.50) KDM4EALDH1A1MAPTHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8778512-B2 Chemical compound for organic electronic device and organic electronic device NOVALED AG (DE) 2014-07-15 US disclosed
EP-2452946-B1 Pyridylphosphinoxides for organic electronic device and organic electronic device NOVALED AG (DE) 2014-05-07 EP disclosed
EP-2463927-B1 Material for organic electronic device and organic electronic device NOVALED AG (DE) 2013-08-21 EP disclosed
EP-2463927-A1 Material for organic electronic device and organic electronic device Novaled AG (DE) 2012-06-13 EP disclosed
US-20120119191-A1 Chemical Compound for Organic Electronic Device and Organic Electronic Device NOVALED AG (DE) 2012-05-17 US disclosed
EP-2452946-A1 Pyridylphosphinoxides for organic electronic device and organic electronic device Novaled AG (DE) 2012-05-16 EP disclosed
EP-2381502-A1 Organic semiconducting layer Novaled AG (DE) 2011-10-26 EP disclosed
EP-2161272-A1 Phenanthrolines BASF SE (DE) 2010-03-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120119191-A1 Chemical Compound for Organic Electronic Device and Organic Electronic Device SLCO4C1, OR10J3, EPCAM KDM4E 1187/4885ALDH1A1 409/4885MAPT 2019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.